跳至主要内容
临床试验/NCT05926076
NCT05926076尚未招募不适用

Comparative Study of COVID-19 Infection in Renal Transplant Recipients and Non Transplant Recipients

Tianjin First Central Hospital1 个研究点 分布在 1 个国家目标入组 610 人开始时间: 2023年7月25日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
610
试验地点
1
主要终点
ICU admission or death

研究概览

简要总结

Post-transplant patients with COVID-19 infection who attended Shenzhen No. 3 Hospital from December 2022 to February 2023, and enrolled the general population with COVID-19 infection who were hospitalized during the same period, matched by age and gender.

详细描述

Data collection:Age, BMI, underlying comorbidities and other basic information were collected retrospectively from the two groups. The medical records were used to collect information about the patients' new coronavirus infection, such as the time of onset of symptoms, time of diagnosis, time of conversion and common symptoms such as fever, cough, nasal congestion and runny nose, muscle aches and pains.To compare the differences of the diagnosis and treatment of KTRs and the general population infected with Omicron

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Confirmed novel coronavirus infection between December 2022 to February 2023,

排除标准

  • Age less than 18; failure of the transplanted kidney before the new coronavirus infection; exclusion of oral immunosuppressed and other types of organ transplant recipients from the non-renal transplant population

结局指标

主要结局

ICU admission or death

时间窗: through study completion, an average of 1 month

patients have ICU admission or death

次要结局

未报告次要终点

研究者

发起方
Tianjin First Central Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Yingxin FU.MD

Head of department

Tianjin First Central Hospital

研究点 (1)

Loading locations...

相似试验